Skip to main content

Advertisement

SpringerLink
Log in

Prognostic value of N1c in colorectal cancer: a large population-based study using propensity score matching

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Purpose

We conducted this large population-based study to investigate the prognostic significance of N1c.

Methods

Patients diagnosed with colorectal cancer from the surveillance, epidemiology, and end results (SEER) database between January 1, 2010, and December 31, 2010, were included in the sample. The primary outcome of interest used in our study was cause-specific survival (CSS). Cox proportional hazards models and Kaplan–Meier methods were used to evaluate the prognostic value of N1c. Propensity score matching (PSM) was implemented to reduce the possibility of selection bias using a logistic regression model.

Results

A total of 19,991 patients diagnosed with colorectal cancer were identified from the SEER database. The median follow-up time of the whole cohort was 60 months (0–71 months).

Multivariate Cox analysis showed that N1c was associated with significantly higher risk of colorectal cancer-specific mortality compared with N0 (HR = 1.962, 95%CI = 1.642 to 2.343, P < 0.001) and N1a (HR = 0.818, 95%CI = 0.678 to 0.987, P = 0.036); N1c was associated with significantly lower risk of colorectal cancer-specific mortality compared with N2a (HR = 1.296, 95%CI = 1.081 to 1.554, P = 0.005) and N2b (HR = 1.663, 95%CI = 1.391 to 1.989, P < 0.001). Yet the CSS difference between N1b and N1c did not achieve statistical difference (HR = 1.089, 95%CI = 0.909 to 1.304, P = 0.354).

Conclusions

The large population-based and propensity score-matched study with long follow-up time provides the first evidence that CSS difference between N1b and N1c does not achieve a statistical difference.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424

    Article  Google Scholar 

  2. Morgane B, Ben C, Nicolas G et al Prognostic value and characteristics of N1c colorectal cancer. Color Dis

  3. Qi L, Luo D, Cai S et al (2018) P–TNM staging system for colon cancer: combination of P-stage and AJCC TNM staging system for improving prognostic prediction and clinical management. Cancer Manag Res 10:2303–2314

    Article  Google Scholar 

  4. Gabriel WB, Dukes C, Bussey HJR (1935) Lymphatic spread in cancer of the rectum. BJS 23(90):395–413

    Article  Google Scholar 

  5. Lord AC, D'Souza N, Pucher PH, Moran BJ, Abulafi AM, Wotherspoon A, Rasheed S, Brown G (2017) Significance of extranodal tumour deposits in colorectal cancer: a systematic review and meta-analysis. Eur J Cancer 82:92–102

    Article  PubMed  Google Scholar 

  6. Belt EJT, Stijn MFM, Van Bril H, ., et al. Lymph node negative colorectal cancers with isolated tumor deposits should be classified and treated as stage III. Ann Surg Oncol, 2010,17(12):3203–3211

    Article  PubMed  PubMed Central  Google Scholar 

  7. Goldstein NS, Turner JR (2000) Pericolonic tumor deposits in patients with T3N+MO colon adenocarcinomas: markers of reduced disease free survival and intra-abdominal metastases and their implications for TNM classification. Cancer 88(10):2228–2238

    Article  CAS  PubMed  Google Scholar 

  8. Lin-Lin T, Peng G, Zhen-Ning W et al (2012) Is the seventh edition of the UICC/AJCC TNM staging system reasonable for patients with tumor deposits in colorectal cancer? Ann Surg 255(2):208–213

    Article  Google Scholar 

  9. Ming J, Rachel R, Rock JB et al (2015) The impact of tumor deposits on colonic adenocarcinoma AJCC TNM staging and outcome. Am J Surg Pathol 39(1):109

    Article  Google Scholar 

  10. Prabhudesai A, Arif S, Finlayson CJ, Kumar D (2003) Impact of microscopic extranodal tumor deposits on the outcome of patients with rectal cancer. Dis Colon Rectum 46(11):1531–1537

    Article  PubMed  Google Scholar 

  11. Yamano T, Semba S, Noda M et al (2015) Prognostic significance of classified extramural tumor deposits and extracapsular lymph node invasion in T3–4 colorectal cancer: a retrospective single-center study. BMC Cancer 15(1):1–9

    Article  Google Scholar 

  12. Mayo E, Llanos AA, Yi X et al (2016) Prognostic value of tumor deposit and perineural invasion status in colorectal cancer patients: a seer-based population study. Histopathology 69(2):230–238

    Article  PubMed  Google Scholar 

  13. Wei XL, Qiu MZ, Zhou YX, He MM, Luo HY, Wang FH, Zhang DS, Li YH, Xu RH (2016) The clinicopathologic relevance and prognostic value of tumor deposits and the applicability of N1c category in rectal cancer with preoperative radiotherapy. Oncotarget 7(46):75094–75103

    PubMed  PubMed Central  Google Scholar 

  14. Basnet S, Lou QF, Liu N, Rana R, Shah A, Khadka M, Warrier H, Sigdel S, Dhakal S, Devkota A, Mishra R, Sapkota G, Zheng L, Ge HY (2018) Tumor deposit is an independent prognostic indicator in patients who underwent radical resection for colorectal cancer. J Cancer 9(21):3979–3985

    Article  PubMed  PubMed Central  Google Scholar 

  15. Joon Seon S, Hee Jin C, Dae Yong K et al (2011) Is the N1C category of the new American Joint Committee on cancer staging system applicable to patients with rectal cancer who receive preoperative chemoradiotherapy? Cancer 117(17):3917–3924

    Article  Google Scholar 

  16. Nagtegaal ID, Quirke P (2007) Colorectal tumour deposits in the mesorectum and pericolon; a critical review [M]

  17. Chavali LB, Llanos AAM, Yun JP et al (2017) Radiotherapy for patients with resected tumor deposit–positive colorectal cancer: a surveillance, epidemiology, and end results–based population study. Arch Pathol Lab Med:arpa.2017-0099-OA

  18. Katharina W, Jenny M, Hendrik JH et al (2010) Shape is not associated with the origin of pericolonic tumor deposits. Am J Clin Pathol 133(3):388–394

    Article  Google Scholar 

  19. Quirke P, Morris E (2010) Reporting colorectal cancer. Histopathology 50(1):103–112

    Article  Google Scholar 

  20. Frankel WL, Jin M (2015) Serosal surfaces, mucin pools, and deposits, oh my: challenges in staging colorectal carcinoma. Mod Pathol 28(Suppl 1(7)):S95

    Article  PubMed  Google Scholar 

  21. Song YX, Gao P, Wang ZN, Liang JW, Sun Z, Wang MX, Dong YL, Wang XF, Xu HM (2012) Can the tumor deposits be counted as metastatic lymph nodes in the UICC TNM staging system for colorectal cancer? PLoS One 7(3):e34087

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Nagtegaal ID, Tibor T, Jayne DG et al (2011) Lymph nodes, tumor deposits, and TNM: are we getting better? J Clin Oncol 29(18):2487–2492

    Article  PubMed  Google Scholar 

  23. Rock JB, Washington MK, Adsay NV et al (2014) Debating deposits: an interobserver variability study of lymph nodes and pericolonic tumor deposits in colonic adenocarcinoma. Arch Pathol Lab Med 138(5):636–642

    Article  PubMed  Google Scholar 

  24. Puppa G, Ueno H, Kayahara M, Capelli P, Canzonieri V, Colombari R, Maisonneuve P, Pelosi G (2009) Tumor deposits are encountered in advanced colorectal cancer and other adenocarcinomas: an expanded classification with implications for colorectal cancer staging system including a unifying concept of in-transit metastases. Mod Pathol 22(3):410–415

    Article  CAS  PubMed  Google Scholar 

  25. Wünsch K, Müller J, Jähnig H, Herrmann RA, Arnholdt HM, Märkl B (2010) Shape is not associated with the origin of pericolonic tumor deposits. Am J Clin Pathol 133(3):388–394

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Colorectal Surgery, Tongde Hospital of Zhejiang Province, 234 Gucui Road, Hangzhou, 310012, Zhejiang, China

    Feng Shen & Xia Hong

Authors
  1. Feng Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xia Hong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xia Hong.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Supplementary Figure 1

Histograms of propensity score before and after PSM. (PDF 5.32 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shen, F., Hong, X. Prognostic value of N1c in colorectal cancer: a large population-based study using propensity score matching. Int J Colorectal Dis 34, 1375–1383 (2019). https://doi.org/10.1007/s00384-019-03328-9

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-019-03328-9

Keywords

Search

Navigation